TY - JOUR T1 - Determining the axillary nodal status with four current imaging modalities including <sup>18</sup>F-FDG PET/MRI in newly diagnosed breast cancer: A comparative study using histopathology as reference standard JF - Journal of Nuclear Medicine JO - J Nucl Med DO - 10.2967/jnumed.121.262009 SP - jnumed.121.262009 AU - Janna Morawitz AU - Nils-Martin Bruckmann AU - Frederic Dietzel AU - Tim Ullrich AU - Ann-Kathrin Bittner AU - Oliver Hoffmann AU - Svjetlana Mohrmann AU - Lena Haeberle AU - Marc Ingenwerth AU - Lale Umutlu AU - Wolfgang Peter Fendler AU - Tanja Fehm AU - Ken Herrmann AU - Gerald Antoch AU - Lino Morris Sawicki AU - Julian Kirchner Y1 - 2021/05/01 UR - http://jnm.snmjournals.org/content/early/2021/05/20/jnumed.121.262009.abstract N2 - Purpose: To compare breast magnetic resonance imaging (MRI), thoracal MRI, thoracal 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET)/MRI and axillary sonography for the detection of axillary lymph node metastases in women with newly diagnosed breast cancer. Materials and Methods: This prospective double-center study included patients with newly diagnosed breast cancer between March 2018 and December 2019. Patients underwent thoracal (18F-FDG PET/)MRI, axillary sonography, and dedicated prone breast MRI. Datasets were evaluated separately regarding nodal status (nodal+ vs. nodal-). Histopathology served as reference standard in all patients. The diagnostic performance of breast MRI, thoracal MRI, thoracal PET/MRI and axillary sonography in detecting nodal positive patients was tested by creating receiver-operating-characteristic curves (ROC) with a calculated area under the curve (AUC). Sensitivity, specificity, positive predictive value, negative predictive value, and accuracy were calculated for all four modalities. A McNemar test was used to assess differences. Results: 112 female patients (mean age 53.04 ± 12.6 years) were evaluated. Thoracal PET/MRI showed the highest ROC-AUC with a value of 0.892. The AUC for breast MRI, thoracal MRI and sonography were 0.782, 0.814 and 0.834, respectively. Differences between thoracal PET/MRI and axillary sonography, thoracal MRI and breast MRI were statistically significant (PET/MRI vs. axillary sonography, P = 0.01; PET/MRI vs. thoracal MRI, P = 0.02; PET/MRI vs. breast MRI, P = 0.03). PET/MRI showed the highest sensitivity (81.8%, 36/44) (95%-CI: 67.29-91.81%) while axillary sonography had the highest specificity (98.5%, 65/66), 95%-CI: 91.84-99.96%). Conclusion: 18F-FDG PET/MRI outperforms axillary sonography, breast MRI and thoracal MRI in determining the axillary lymph node status. In a clinical setting, the combination of 18F-FDG PET/MRI and axillary sonography might be considered to provide even more accuracy in diagnosis. ER -